CN
Product Telephone +86-731-88207415 Message
Home>Product>APIs
Ticagrelor

CAS:274693-27-5

Chemical Name1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol

Molecular Formula: C23H28F2N6O4S

Molecular Weight: 522.574

Packing:25kg/Drum Or As you request

Purity:98% 

Send Inqury
Product Description

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.

 

It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.


About IntroductionCultureHistory News HWCPharm NewsMedia Report Product APIsIntermediatesImpurity ReferenceExcipients R&D & Service CpercCMOCRO Quality&EHS QAQCEHS Contact Contact UsJoin Us